Aspirin continues to show promise as a potent anti-cancer drug, with new findings showing that women taking aspirin two or more times a week may lower their risk of leukemia by more than 50%.
The study, led by Julie Ross, associate professor of pediatrics and a member of the University of Minnesota Cancer Center, is published in the June 13 edition of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Ross and her team analyzed data from the Iowa Women’s Health Study, which has been tracking health, lifestyle, behavior and incidence of cancer for 41,000 post-menopausal women since 1985.
